Skip to main content
رجوع
Watch Compare

Alzamend Neuro, Inc.

جودة البيانات: 83%
ALZN
NASDAQ Manufacturing Chemicals
KWD 1.02
▼ KWD 0.02 (-1.92%)
6 months return
—
Momentum
Neutral
ROE
-317.66%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-317.66%
أقل من متوسط القطاع (-54.47%)
ROIC-179.78%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-424.23

التقييم

PE (TTM|NTM)
-0.33 | -0.33
أعلى من متوسط القطاع (-1.49)
P/B Ratio1.57
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -11.84 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

محلل 1
Buy
+2351.0%
upside to target
الحالي
KWD 1.02
Consensus Target
KWD 25.00
KWD 25.00
أدنى
KWD 25.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-0.33
ربحية السهم المستقبلية
-KWD 2.60
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q2 2026 · EPS Est: -KWD 0.67 · Rev Est: 0.0
2026-Q2 2026-Q3 Q22025 Q32025 Q42025 Q12026 Q2 '26 Q3 '26
Reported -KWD 0.05 -KWD 0.56 -KWD 9.48 -KWD 1.28 -KWD 0.30 -KWD 0.58 — —
Estimate -KWD 0.67 -KWD 0.67 -KWD 2.70 -KWD 0.69 -KWD 1.96 -KWD 0.53 -KWD 0.67 -KWD 0.67
المفاجأة +92.54% +16.42% -251.11% -85.51% +84.65% -9.43% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -317.66% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -10.42 M
ROE -317.66% ROA -228.11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -11.84 M
ROIC -179.78% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage -424.23 Asset Turnover N/A
Working Capital N/A Tangible Book Value 2.18 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.33 · EV/EBITDA: N/A
P/E Ratio -0.33 Forward P/E -0.33
P/B Ratio 1.57 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -344.77%
Market Cap 3.43 M Enterprise Value 720,639.0

Per Share

EPS: -13.21 · FCF/Share: -3.11
EPS (Diluted TTM) -13.21 Revenue / Share N/A
FCF / Share -3.11 OCF / Share -3.11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 113.64% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 113.64%
SBC-Adj. FCF -12.00 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -4.51 M -9.95 M -14.88 M -12.36 M -5.05 M
EPS (Diluted) -11.32 -14.70 -0.15 — —
Gross Profit — — — — —
Operating Income -4.50 M -9.94 M -14.87 M -12.32 M -4.95 M
EBITDA — — — — —
R&D Expenses 1.41 M 6.46 M 7.45 M 5.20 M 1.31 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 18,029.0 10,101.0 7,701.0 46,524.0 142,421.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4.60 M 631,588.0 5.92 M 14.52 M 2.91 M
Total Liabilities 634,761.0 3.23 M 2.87 M 1.16 M —
Shareholders' Equity 3.97 M -2.59 M 3.05 M 13.35 M 2.01 M
Total Debt — — — — —
Cash & Equivalents 3.95 M 376,048.0 5.14 M 14.06 M 1.93 M
Current Assets 4.18 M 455,242.0 5.84 M 14.41 M 2.91 M
Current Liabilities — — 2.87 M 1.16 M 899,643.0

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -0.3 -1.5
P/B 1.6 1.6
ROE % -317.7 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3